Es gab 50 kürzliche Insider-Transaktionen für Envista Holdings Corp (NVST), darunter 36 Käufe und 11 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.05M und die gesamten Insider-Verkäufe auf $3.39M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Hammes Eric D., Keel Paul A, Nance Mark E. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NVST
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU-Zuteilung |
29,225 |
- |
- |
29,225 |
| 2026-02-25 |
Keel Paul A |
Chief Executive Officer |
RSU-Zuteilung |
115,320 |
$29.59 |
$3.41M |
115,320 |
| 2026-02-25 |
Nance Mark E |
General Counsel |
RSU-Zuteilung |
23,070 |
- |
- |
23,070 |
| 2026-02-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU-Zuteilung |
10,770 |
- |
- |
10,770 |
| 2026-02-25 |
Kaabi Faez C |
Chief Accounting Officer |
RSU-Steuereinbehalt |
4,964 |
$29.59 |
$146.88K |
45,032 |
| 2026-02-25 |
Befidi Robert |
President, Diagnostics |
RSU-Zuteilung |
13,845 |
- |
- |
13,845 |
| 2026-02-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU-Zuteilung |
13,845 |
- |
- |
13,845 |
| 2026-02-25 |
Acurio Veronica |
President, Orthodontics |
RSU-Zuteilung |
13,845 |
- |
- |
13,845 |
| 2026-02-10 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
Optionsausübung (Verkauf) |
5,634 |
$15.97 |
$89.97K |
- |
| 2026-02-01 |
Hammes Eric D. |
Chief Financial Officer |
RSU-Zuteilung |
1,119 |
- |
- |
1,119 |
| 2026-02-01 |
Keel Paul A |
Chief Executive Officer |
RSU-Zuteilung |
4,091 |
- |
- |
4,091 |
| 2026-02-01 |
Nance Mark E |
General Counsel |
RSU-Zuteilung |
2,006 |
- |
- |
7,587 |
| 2026-02-01 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU-Zuteilung |
2,919 |
- |
- |
29,357 |
| 2026-02-01 |
Kaabi Faez C |
Chief Accounting Officer |
RSU-Zuteilung |
1,186 |
- |
- |
5,040 |
| 2026-02-01 |
Befidi Robert |
President, Diagnostics |
RSU-Zuteilung |
998 |
- |
- |
2,149 |
| 2026-02-01 |
Acurio Veronica |
President, Orthodontics |
RSU-Zuteilung |
998 |
- |
- |
998 |
| 2025-11-01 |
Keel Paul A |
Chief Executive Officer |
RSU-Steuereinbehalt |
54,097 |
$20.35 |
$1.1M |
347,555 |
| 2025-08-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU-Steuereinbehalt |
7,654 |
$21.12 |
$161.65K |
96,788 |
| 2025-08-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
Informierter Verkauf |
15,000 |
$21.60 |
$324K |
32,382 |
| 2025-08-25 |
Befidi Robert |
President, Diagnostics |
RSU-Steuereinbehalt |
3,454 |
$21.12 |
$72.95K |
45,504 |
| 2025-08-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU-Steuereinbehalt |
804 |
$21.12 |
$16.98K |
54,941 |
| 2025-08-25 |
Acurio Veronica |
President, Orthodontics |
RSU-Steuereinbehalt |
5,422 |
$21.12 |
$114.51K |
50,323 |
| 2025-07-14 |
Pierce James Andrew |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-07-14 |
Pierce James Andrew |
Director |
RSU-Zuteilung |
9,155 |
- |
- |
9,155 |
| 2025-06-10 |
Tsingos Christine A |
Director |
RSU-Zuteilung |
10,450 |
- |
- |
50,600 |
| 2025-06-10 |
Raskas Daniel |
Director |
RSU-Zuteilung |
10,450 |
- |
- |
44,680 |
| 2025-06-10 |
Gallahue Kieran |
Director |
RSU-Zuteilung |
10,450 |
- |
- |
44,680 |
| 2025-06-10 |
Huennekens R Scott |
Director |
RSU-Zuteilung |
14,370 |
- |
- |
69,520 |
| 2025-06-10 |
Jain Vivek |
Director |
RSU-Zuteilung |
10,450 |
- |
- |
43,615 |
| 2025-06-10 |
Carruthers Wendy |
Director |
RSU-Zuteilung |
10,450 |
- |
- |
50,610 |
| 2025-06-10 |
Hulit Barbara B. |
Director |
RSU-Zuteilung |
10,450 |
- |
- |
79,820 |
| 2025-05-25 |
Keel Paul A |
Chief Executive Officer |
RSU-Steuereinbehalt |
12,787 |
$16.72 |
$213.8K |
401,652 |
| 2025-02-26 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU-Zuteilung |
8,475 |
- |
- |
47,382 |
| 2025-02-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU-Zuteilung |
28,995 |
- |
- |
28,995 |
| 2025-02-25 |
Keel Paul A |
Chief Executive Officer |
RSU-Zuteilung |
153,660 |
$20.66 |
$3.17M |
153,660 |
| 2025-02-25 |
Nance Mark E |
General Counsel |
RSU-Zuteilung |
33,455 |
- |
- |
33,455 |
| 2025-02-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU-Zuteilung |
15,615 |
- |
- |
15,615 |
| 2025-02-25 |
Kaabi Faez C |
Chief Accounting Officer |
RSU-Zuteilung |
22,600 |
$20.66 |
$466.92K |
22,600 |
| 2025-02-25 |
Befidi Robert |
President, Diagnostics |
RSU-Zuteilung |
18,960 |
- |
- |
18,960 |
| 2025-02-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU-Zuteilung |
18,960 |
- |
- |
18,960 |
| 2025-02-25 |
Acurio Veronica |
President, Orthodontics |
RSU-Zuteilung |
18,960 |
- |
- |
18,960 |
| 2025-02-01 |
Nance Mark E |
General Counsel |
RSU-Zuteilung |
965 |
- |
- |
5,581 |
| 2025-02-01 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU-Zuteilung |
3,152 |
- |
- |
26,438 |
| 2025-02-01 |
Kaabi Faez C |
Chief Accounting Officer |
RSU-Zuteilung |
689 |
- |
- |
3,854 |
| 2025-02-01 |
Befidi Robert |
President, Diagnostics |
RSU-Zuteilung |
1,151 |
- |
- |
1,151 |
| 2024-11-18 |
Nilsson Stefan |
President, Nobel Biocare |
Unbekannt |
- |
- |
- |
45,455 |
| 2024-11-18 |
Acurio Veronica |
President, Orthodontics |
Unbekannt |
- |
- |
- |
45,455 |
| 2024-11-01 |
Keel Paul A |
Chief Executive Officer |
RSU-Steuereinbehalt |
53,996 |
$20.94 |
$1.13M |
348,609 |
| 2024-09-17 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU-Steuereinbehalt |
812 |
$19.00 |
$15.43K |
42,720 |
| 2024-08-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU-Zuteilung |
64,175 |
- |
- |
88,707 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
